当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
SHERPA: a new model for clinical decision making in patients with multimorbidity
The Lancet ( IF 98.4 ) Pub Date : 2018-10-20 , DOI: 10.1016/s0140-6736(18)31371-0
Edmund Jack , Neal Maskrey , Richard Byng

Data on how to improve the care of patients with multimorbidity are lacking. Evidence-based medicine and the teaching of consultation skills—two of the cornerstones of modern clinical practice—are not sufficient for making decisions with and for patients with multimorbidity. Therefore, we have developed a new model that supports the translation of population-based, evidence-based medicine and complex consultation models into simpler, natural conversations about care appropriate for and agreed with individual patients.

中文翻译:

SHERPA:一种用于多发病的临床决策的新模型

缺乏有关如何改善多发病率患者护理的数据。循证医学和咨询技能的教学是现代临床实践的两个基石,不足以对多发病率患者和对多发病率患者做出决策。因此,我们开发了一种新的模型,该模型支持将基于人群的循证医学和复杂的咨询模型转换为更简单,自然的有关适合患者并已获得患者同意的护理对话。
更新日期:2018-10-19
down
wechat
bug